Because I'm not a trader. My view isn't next week or next month, I'm looking at 2029+
I believe that FDA approval is a matter of course and will simply be a green light to market. I'm here for post FDA approval, and the risk to me is how the market reacts to Sofrada. I am happy to take that particular risk as the Japanese market is already showing signs of sucess. Sofrada as a product sits in a sweet spot in terms of treatment where efficacy is (seemingly) good and is a non invasive treatment.
So for me, yes, I priced FDA approval into the current SP. In my mind, I purchased BOT because the likelyhood of FDA approval is extremely high. As I said in a previous post, I'm working on a 0.55 SP next year and I'm happy with that.
- Forums
- ASX - By Stock
- BOT
- Ann: Final Sofdra Labelling Discussions with FDA
Ann: Final Sofdra Labelling Discussions with FDA, page-85
-
-
- There are more pages in this discussion • 198 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
38.0¢ |
Change
0.055(16.9%) |
Mkt cap ! $687.8M |
Open | High | Low | Value | Volume |
33.0¢ | 38.0¢ | 33.0¢ | $7.103M | 19.63M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 134000 | 37.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.0¢ | 650314 | 19 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 132500 | 0.375 |
3 | 7752 | 0.370 |
2 | 24000 | 0.365 |
1 | 4166 | 0.360 |
3 | 59669 | 0.355 |
Price($) | Vol. | No. |
---|---|---|
0.380 | 502144 | 15 |
0.385 | 164500 | 4 |
0.390 | 276986 | 11 |
0.395 | 750000 | 5 |
0.400 | 660032 | 20 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |